SCHEMBL7463584

SCHEMBL7463584

Cc1ccc(NC(=O)N[C@H](CN)C(=O)NO)cc1

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 4/20 0.54
FPR2 P25090 3/20 0.48
NPC1 O15118 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27544570 0.85 ANPEP (0.51) ANPEPFPR2
SCHEMBL7419417 0.85 ANPEP (0.49) ANPEPFPR2
SCHEMBL7416181 0.81 FPR2 (0.62) ANPEPFPR2
SCHEMBL7419891 0.78 MAPT (0.53) ANPEPNPC1POLB
SCHEMBL7411160 0.76 FPR2 (0.57) ANPEPFPR2POLB
SCHEMBL1109398 0.75 HDAC1 (0.49)
SCHEMBL7415730 0.75 NPC1 (0.54) FPR2NPC1POLB
SCHEMBL8103174 0.75 FPR2 (0.49) ANPEPFPR2NPC1POLB
SCHEMBL19201543 0.75 FPR2 (0.76) ANPEPFPR2
SCHEMBL18053826 0.74 PTPN7 (0.54) NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed